| |
| |
|
| Insider
Information: |
Onaitis Matthew |
| Relationship: |
Gnrl Counsel, CFO & Se... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
15,872 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,872 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
SVP, General Counsel |
2013-03-06 |
0 |
2007-10-08 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Gnrl Counsel, CFO & Se... |
2017-09-18 |
15,872 |
2017-09-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDTX |
Cidara Therapeutics, Inc. |
Gnrl Counsel, CFO & Secretary |
• – – |
2017-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,872 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• • – |
2013-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,098) |
0 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,494 |
54,837 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2012-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
57,093 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2012-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,716 |
186,745 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,992 |
171,029 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2012-01-03 |
4 |
AS |
$0.48 |
$4,290 |
D/D |
(9,000) |
155,037 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2011-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
144,037 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2010-12-01 |
4 |
AS |
$2.68 |
$22,724 |
D/D |
(8,468) |
64,037 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, General Counsel |
• – – |
2010-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
60,005 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-03-18 |
4 |
AS |
$6.59 |
$247,357 |
D/D |
(32,081) |
30,005 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-03-18 |
4 |
OE |
$1.23 |
$36,228 |
D/D |
29,454 |
59,459 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-03-18 |
4 |
D |
$3.94 |
$21,985 |
D/D |
(5,580) |
32,632 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-03-01 |
4 |
AS |
$4.02 |
$120,465 |
D/D |
(30,000) |
0 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-03-01 |
4 |
OE |
$1.23 |
$36,900 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-02-05 |
4 |
OE |
$1.23 |
$73,800 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2010-02-05 |
4 |
AS |
$3.03 |
$181,506 |
D/D |
(60,000) |
0 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2009-12-31 |
4 |
AS |
$1.07 |
$5,350 |
D/D |
(5,000) |
50,712 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2009-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,848 |
74,560 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2008-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
55,712 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2008-04-14 |
4 |
D |
$4.66 |
$8,332 |
D/D |
(1,788) |
18,212 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
VP, General Counsel |
• – – |
2007-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
